Pharmaceuticals · PH-10 · Packaging line productivity

$2 bn in imports. Are your lines running at full capacity?

The government aims to cut medicine imports and expand local production. Output is growing by around 30%. Before building a new line, you need to know how much time your existing lines are actually running.

Platform: Plant Pulse

+29.4%

Production growth, January–May 2026.1

$2 bn

Medicine imports in 2025.2

UZS 8.5 trn

2026 production target.3

A line that is running is not necessarily producing.

Who it is for

CEO
Capacity.
Production
Plan.
Engineer
Downtime.
QA
Changeover cleanliness.

Where the problem lies

  • Changeover

    Product changeovers and cleaning take a long time.

  • Minor stops

    Short stops that are not recorded.

  • Speed

    The line runs below its rated speed.

  • Rejects

    Defective blisters and cartons.

How the loss is calculated

Downtimedowntime hours × output per hour (units/h) × margin per unit
Changeovernumber of changeovers × duration per changeover (h)
Speed(rated speed − actual speed, units/h) × operating hours
Rejectsrejected units × unit cost

Calculate with your data

Packaging line changeover time: lost capacity estimate

This calculator estimates the time one packaging line spends on product changeovers per month.

Use spaces for thousands and a dot or comma for decimals. Use the same currency throughout.

Values stay in this page and are not sent to the server.

Scenario estimate

0 / 6 values entered

Enter your operating figures to see the estimate.

You set the target changeover time yourself. It is not presented as achievable and must be confirmed through an audit, trials and GMP-compliant qualification. Freed time creates value only if demand, materials, packaging components and staff are available. The calculation uses contribution margin, not revenue. It does not confirm validation documents, GMP/GDP compliance or any inspection outcome. No exact timeline or price can be given without an audit.

Formulas and assumptions

This calculator estimates the time one packaging line spends on product changeovers per month. It compares your current changeover duration with a target duration that you enter. It then shows the hours freed, the extra units that could be packed and an estimate of contribution margin. Margin is counted only on the share of extra output you expect to sell. Enter values from your own measurements, such as MES or OEE records. Downtime, speed losses, rejects, labour, validation and investment costs are excluded. All results are estimates, not guaranteed outcomes.

Baseline: time spent on changeovers
Changeovers per month × current duration (min) ÷ 60 = hours per month.
Scenario: changeover time at target duration
Changeovers per month × target duration (min) ÷ 60 = hours per month. The number of changeovers is assumed to stay the same.
Freed packaging capacity
max(0; current − target duration, min) × changeovers per month ÷ 60 × actual output rate (units/h). This is potential capacity, not sales.
Estimated contribution margin from freed capacity
Freed units (units/month) × sellable share (%) ÷ 100 × contribution margin per unit (currency/unit). This is an estimate of potential value, not guaranteed savings.

Facts and global practice

  • National Statistics Committee

    In January–May 2026, pharmaceutical production exceeded UZS 2.3 trn, up 29.4%.1

  • Customs Committee (kun.uz)

    Medicine imports reached $2 bn in 2025; a goal has been set to replace imports with local production.2

  • yuz.uz

    2026 target: UZS 8.5 trn, with $800 mn in projects.3

  • Reliamag

    Körber PAS-X MES includes a KPI/OEE module.4

No public data was found on OEE for pharmaceutical lines in Uzbekistan.

OEE — every shift

Run, stop and counter data are collected from line signals; the operator selects the stop reason; OEE is calculated per shift.

  1. 01Signal
    • Run
    • Stop
    • Counter
  2. 02Reason
    • Operator
    • Changeover
    • Breakdown
  3. 03Calculation
    • Availability
    • Performance
    • Quality
  4. 04Report
    • Shift
    • Line
    • Trend

Modules

The current maturity level is shown next to each module.

Line signal collectionPLC/sensorEngineering capability
Stop reasonsOperator panelEngineering capability
OEE reportShiftEngineering capability
Batch linkageWMSCommercially available

How we start

  1. 01

    Line audit

    Signals and process.

    Outcome: measurement plan.

  2. 02

    Pilot

    One line, 30 days.

    Outcome: OEE baseline.

  3. 03

    Scale-up

    All lines.

    Outcome: plant-wide OEE.

  4. 04

    Subscription

    Monthly.

    Outcome: trend.

What is measured

OEE%System
Changeover timeMinutesSystem
Minor stopsCountSignal
Rejects%Counter

What is needed to start

  • Head of production
  • List of lines
  • PLC data
  • Shift schedule

What we do not promise

  • Firm timelines and prices without an audit
  • GMP/GDP certification or inspection outcomes
  • Approving validation documents on the client's behalf
  • Results that have not been measured

Self-check

  1. Is OEE measured?
  2. Are stop reasons recorded?
  3. Is changeover time known?
  4. Are minor stops recorded?
  5. Does the line run at its rated speed?
  6. Are rejects visible by line?
  7. Are shifts compared?
  8. Are new-line decisions based on OEE?
  9. Is the data linked to batches?
  10. Is there a designated owner?

Line audit

We measure an OEE baseline on one packaging line.

  • Map of gaps and break points
  • Pilot plan
  • Implementation fee and monthly subscription

Sources

  1. National Statistics Committee: pharmaceutical production, January–May 2026. kun.uz, 16.07.2026.
  2. "Uzbekistan seeks to cut $2bn medicine imports". kun.uz, 27.02.2026 (under the Presidential decree of 23.01.2024).
  3. Decree of 05.03.2026 on stimulating the pharmaceutical sector: 2026 targets. yuz.uz, 2026.
  4. Reliamag: "Best MES for Pharmaceutical Manufacturing 2026: an independent comparison". 2026.